About | Toxometris.ai

ABOUT US

Our Mission

The mission of our company is to accelerate the drug development process by continuously inventing and deploying new artificial intelligence and cell culture technologies. We provide AI solutions to the pharma and biotechnology companies to optimize and minimize the experimental part of drugs standard safety assessment processes, as well as perform accelerated end-to-end safety assessment studies using hybrid in silico/in vitro models.

Our vision

Toxometris.ai aims to replace standard safety assessment methods with hybrid in silico/in vitro accelerated models in accordance with the requirements to appropriate toxicity endpoints. Our goal is to provide the integrated package of safety assessment solutions during the drug development process to obtain human relevant data avoiding time and cost overruns.

OUR SERVICE MODELS

IN VITRO TOXICITY ASSESSMENT

Standard and/or cutting edge, rapid, high-efficient and cost-effective in vitro assays to estimate drug candidates safety risks recommended by most regulatory authorities

IN SILICO TOXICITY PREDICTION

Service that delivers a combination of powerful computation models to predict physicochemical properties and toxicological endpoints for small molecules

HYBRID IN SILICO/IN VITRO TOXICITY ASSESSMENT

Service using hybrid models, where in silico virtual predictions using ai/ml will shorten the duration and decrease the cost of safety assessment process, while in vitro models will ensure the reliability of virtual predictions

AI/ML SERVICES

To help customers to optimize and minimize their experimental part of drugs standard safety assessment processes

CUSTOMIZED ASSAY SERVICE

In case if there is a need of an expert testing consultation at different stages of the drug development process our team can develop methods and protocols based on customer purposes

CONTACT

Anchor 1